Clinical trials
Shock, Cardiogenic trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 9 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Leipzig | 3 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Abiomed Inc. | 2 |
| Charite University, Berlin, Germany | 2 |
| Leipzig Heart Science gGmbH | 2 |
| Martin-Luther-Universität Halle-Wittenberg | 2 |
| Xenios AG | 2 |
| 4TEEN4 Pharmaceuticals GmbH | 1 |
| Abbott Medical Devices | 1 |
| Christian Schulze | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Cardiogenic | 35 |
| Myocardial Infarction | 7 |
| Heart Failure | 5 |
| Heart Arrest | 4 |
| Respiratory Distress Syndrome | 3 |
| Communicable Diseases | 2 |
| Multiple Organ Failure | 2 |
| Sepsis | 2 |
| Shock, Septic | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.